Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Osteosarcoma 1 Bone Neoplasms 1

Interventions

Cisplatin 2 regorafenib 1 endostar protein 1 alectinib 1 Sunitinib 1 Plicamycin 1 Platinum 1 Nivolumab 1 Methotrexate 1 Metastasectomy 1 Ifosfamide 1 Epirubicin 1 Doxorubicin 1 Dacarbazine 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Bone Neoplasms × endostar protein × Clear all

NCT06562673 2025-12-29

IACE-OS

Shanghai 6th People's Hospital

Phase 1/2 Completed

Bone Neoplasms, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡